SPRING 2026 • XLII EDITION
ADVANCING PRECISION MEDICINE OCTOBER 5–8 AND OCTOBER 16–19
October saw two additional critical meetings. At Lake Geneva’s Bella Vista resort, Dr. Jay Sarthy and Dr. Laura Banaszynski brought together pediatric and adult cancer experts, biologists, chemists, and drug developers to explore mutations in histone proteins—the structures that are associated with DNA in our cells. Subtle changes in these proteins have been linked to many types of cancer, particularly in children and young adults. New drugs targeting these mutations are now entering clinical trials. At Evin’s Mill in Tennessee, Dr. Kristopher Sarosiek and Dr. Cristina Munoz Pinedo gathered experts to discuss cell death in cancer therapy—understanding why some cancer cells resist dying when treated and how to overcome resistance across pediatric and adult cancers. THE LONG ROAD AFTER TREATMENT OCTOBER 26–29 Thanks to improving treatments, more children are surviving cancer than ever before. But survival raises new questions: What are the long-term effects of treatment? How can we prevent secondary cancers in survivors? Two back-to- back Forums at The Abbey in Lake Geneva, supported by Curing Kids Cancer, focused on these vital questions. Leading researchers including Dr. Greg Armstrong, Dr. Lindsay Morton, Dr. Melissa Hudson, Dr. Lisa Diller, and Dr. Tara Henderson gathered to ensure that childhood cancer survivors can live full, healthy lives. METABOLIC WARFARE AGAINST CANCER NOVEMBER 13–16 The year concluded with a meeting on one of cancer research’s most promising frontiers: immunometabolism. At the W Mexico City, Dr. Navdeep Chandel and Dr. Susan Kaech led discussions on how cancer cells create hostile environments preventing immune cells from attacking them. By understanding and manipulating cellular metabolism, researchers explored ways to “recharge” immune cells and transform immunotherapy from a treatment that works in 20- 30% of cancers into one that may help many more patients—especially those who have tumors that currently resist treatment. A COMMUNITY OF HOPE What made these Forums special wasn’t just the science—it was the people. Early-career researchers learned from established leaders. Clinicians who see patients every day shared insights with laboratory scientists. Ideas that seemed impossible in isolation became achievable when the right minds connected. Each meeting represented hundreds of hours of planning, thousands of miles traveled, and countless conversations. But they also represented something more: a global community united by a single purpose—to understand cancer better and to translate that understanding into functional treatments. The collaborations forged and insights gained in 2025 are already shaping the next generation of cancer research and treatment approaches that will benefit patients for years to come. For more information about future Forums or to learn about sponsorship opportunities, please visit our scientific website FORBECKFORUMS.ORG . Together, we can accelerate the future of cancer care.
3
Made with FlippingBook. PDF to flipbook with ease